Literature DB >> 23061031

Advances in gastric cancer prevention.

Antonio Giordano1, Letizia Cito.   

Abstract

Gastric cancer is a multifactorial neoplastic pathology numbering among its causes both environmental and genetic predisposing factors. It is mainly diffused in South America and South-East Asia, where it shows the highest morbility percentages and it is relatively scarcely diffused in Western countries and North America. Although molecular mechanisms leading to gastric cancer development are only partially known, three main causes are well characterized: Helicobacter pylori (H. pylori) infection, diet rich in salted and/or smoked food and red meat, and epithelial cadherin (E-cadherin) mutations. Unhealthy diet and H. pylori infection are able to induce in stomach cancer cells genotypic and phenotypic transformation, but their effects may be crossed by a diet rich in vegetables and fresh fruits. Various authors have recently focused their attention on the importance of a well balanced diet, suggesting a necessary dietary education starting from childhood. A constant surveillance will be necessary in people carrying E-cadherin mutations, since they are highly prone in developing gastric cancer, also within the inner stomach layers. Above all in the United States, several carriers decided to undergo a gastrectomy, preferring changing their lifestyle than living with the awareness of the development of a possible gastric cancer. This kind of choice is strictly personal, hence a decision cannot be suggested within the clinical management. Here we summarize the key points of gastric cancer prevention analyzing possible strategies referred to the different predisposing factors. We will discuss about the effects of diet, H. pylori infection and E-cadherin mutations and how each of them can be handled.

Entities:  

Keywords:  Cancer; Cell cycle; Diet; Helicobacter pylori; Lifestyle; Prevention; Vegetables

Year:  2012        PMID: 23061031      PMCID: PMC3468701          DOI: 10.5306/wjco.v3.i9.128

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  128 in total

Review 1.  Helicobacter pylori infection and eradication in paediatric patients.

Authors:  H M Malaty
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 2.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils.

Authors:  R M Peek; H P Wirth; S F Moss; M Yang; A M Abdalla; K T Tham; T Zhang; L H Tang; I M Modlin; M J Blaser
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

4.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.

Authors:  T C Wang; C A Dangler; D Chen; J R Goldenring; T Koh; R Raychowdhury; R J Coffey; S Ito; A Varro; G J Dockray; J G Fox
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

5.  Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.

Authors:  Jed W Fahey; Xavier Haristoy; Patrick M Dolan; Thomas W Kensler; Isabelle Scholtus; Katherine K Stephenson; Paul Talalay; Alain Lozniewski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.

Authors:  Daoyan Wei; Weida Gong; Sang C Oh; Qiang Li; Won Dong Kim; Liwei Wang; Xiangdong Le; James Yao; Tsung T Wu; Suyun Huang; Keping Xie
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

Review 7.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

8.  Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.

Authors:  Tai Young Kim; Hyeon Joo Lee; Kyu Sang Hwang; Minjin Lee; Jae Won Kim; Yung-Jue Bang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2004-04       Impact factor: 5.662

9.  High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.

Authors:  Takao Maekita; Kazuyuki Nakazawa; Mami Mihara; Takeshi Nakajima; Kimihiko Yanaoka; Mikitaka Iguchi; Kenji Arii; Atsushi Kaneda; Tetsuya Tsukamoto; Masae Tatematsu; Gen Tamura; Daizo Saito; Takashi Sugimura; Masao Ichinose; Toshikazu Ushijima
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

10.  Early Helicobacter pylori colonisation: the association with growth faltering in The Gambia.

Authors:  J E Thomas; A Dale; J E G Bunn; M Harding; W A Coward; T J Cole; L T Weaver
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

View more
  8 in total

1.  Efficacy of Omega Fatty Acid Supplementation on mRNA Expression Level of Tumor Necrosis Factor Alpha in Patients with Gastric Adenocarcinoma.

Authors:  Asghar Hosseinzadeh; Seyed Mojtaba Mohaddes Ardebili
Journal:  J Gastrointest Cancer       Date:  2016-09

2.  siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer.

Authors:  Donglei Zhou; Xun Jiang; Weixing Ding; Lijun Zheng; Lei Yang; Chengzhu Zheng; Liesheng Lu
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-28       Impact factor: 4.553

3.  Novel findings about management of gastric cancer: a summary from 10th IGCC.

Authors:  Danila Penon; Letizia Cito; Antonio Giordano
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Rare case of Helicobacter pylori-related gastric ulcer: malignancy or pseudomorphism?

Authors:  Ting-Ting Li; Feng Qiu; Zhi-Qiang Wang; Lu Sun; Jun Wan
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

5.  Pachymic acid inhibits growth and induces cell cycle arrest and apoptosis in gastric cancer SGC-7901 cells.

Authors:  Kuan-Xue Sun; Hong-Wei Xia
Journal:  Oncol Lett       Date:  2018-06-05       Impact factor: 2.967

6.  Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway.

Authors:  Gui-Mei Kong; Wen-Hua Tao; Ya-Li Diao; Peng-Hua Fang; Ji-Jun Wang; Ping Bo; Feng Qian
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

Review 7.  The role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysis.

Authors:  Xuefen Lei; Feng Wang; Yang Ke; Dong Wei; Hou Gu; Zhixian Zhang; Lifeng Jiang; Li Lv; Jie Lin; Lin Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression.

Authors:  Aijun Liao; Gao Tan; Lin Chen; Weiwei Zhou; Hongsai Hu
Journal:  Oncotarget       Date:  2016-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.